Ignite Creation Date:
2024-05-05 @ 5:23 PM
Last Modification Date:
2024-10-26 @ 9:31 AM
Study NCT ID:
NCT00448240
Status:
TERMINATED
Last Update Posted:
2010-02-02
First Post:
2007-03-14
Brief Title:
Erlotinib Tarceva During First Line Standard Platinum Containing Chemo for Advanced Squamous Cell Head and Neck Cancer
Sponsor:
Henry Ford Health System
Organization:
Henry Ford Health System
Organization Data
Organization:
Henry Ford Health System
Class:
OTHER
Study ID:
HFHS 05-03
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Henry Ford Health System
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Haythem Ali MD
Old Organization:
Henry Ford Health System
Collaborators
| Name | Class |
|---|---|
| Genentech Inc | INDUSTRY |